viewWeight Watchers International

Broker roundup, including Weight Watchers, Valeant Pharma and Rogers Communications

The analysts at Barclays took a shine to Weight Watchers (NYSE:WTW) today upgrading the shares to 'equalweight' from 'underweight'.

A look at some of today\\\'s broker views...

The analysts at Barclays took a shine to Weight Watchers (NYSE:WTW) today upgrading the shares to 'equalweight' from 'underweight'.

The target price was also lifted to US$14 a share from US$5.

Ealier this week, it emerged one of the most popular US talk show hosts had taken a stake in the Weight Watchers parent firm.
Oprah Winfrey, the presenter of the eponymously named show, purchased a 10% stake in the global slimming group Weight Watchers International for US$43mln and will take a seat on the board.

Also in broker world on Wednesday, drugs giant GlaxoSmithKline  was pushed up to 'neutral' from 'underperform' by Credit Suisse.

Rogers Communications (TSE:RCI) gained over a percentage point to US$49.68 on the day as Macquarie raised its rating to 'outperfom' from 'neutral'.

On the flipside, CIBC is less upbeat on Valeant Pharmaceuticals International (NYSE: VRX) and downgrades it to 'sector perform' from ' sector outperform'.

Shares lost over 27% to US$106.47.

Quick facts: Weight Watchers International

Price: 37.755 USD

Market: NASDAQ
Market Cap: $2.54 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



CytoDyn reveals more promising results from its clinical trials in breast cancer

CytoDyn Inc (OTCMKTS:CYDY) CEO Nader Pourhassan tells Proactive the late-stage biotechnology company has revealed additional “promising results” from its clinical trials evaluating its lead drug leronlimab for the treatment of metastatic triple-negative breast cancer and metastatic breast...

44 minutes ago

2 min read